Q32 Bio

QTTBNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$464.404 M

$15.60 -3.70%

Close of 7 Aug 2026

Revenue

$53.7M

#2716 by revenue

Earnings

$29.8M

#1755 by earnings

Shares outstanding

29,769,466

Latest filing cover page

P/E ratio

15.6

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#212Ovid TherapeuticsOVID$490.9M
#213Benitec BiopharmaBNTC$468.2M
#214Q32 BioQTTB$464.4M
#215Prothena Corp PublicPRTA$458.6M
#216Puma BiotechnologyPBYI$453.5M

Where these numbers come from

Share counts and financials for Q32 Bio are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.